Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
09:00-09:15 | 09:00-09:15 |
Tumor Treatment and Atrial Fibrillation: Inspirations from the Epidemiological Data |
Zhiren Zhang | Harbin Medical University Cancer Hospital |
09:15-09:22 | 09:15-09:22 |
Discussion |
||
09:22-09:37 | 09:22-09:37 |
Anticoagulation Management of Tumor Patients with Atrial Fibrillation |
Zhiren Zhang | Harbin Medical University Cancer Hospital |
09:37-09:44 | 09:37-09:44 |
Discussion |
||
09:44-09:59 | 09:44-09:59 |
Tumor with Atrial Fibrillation: Is Catheter Ablation Feasible? |
Xiaomeng Yin | |
09:59-10:06 | 09:59-10:06 |
Discussion |
||
10:06-10:21 | 10:06-10:21 |
The Mechanism of Ibrutinib-Induced Atrial Fibrillation |
Nian Liu | |
10:21-10:30 | 10:21-10:30 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
11:00-11:15 | 11:00-11:15 |
Unmet Needs and Management Strategies of Oral Anticoagulation in Patients with Atrial Fibrillation |
Shaowen Liu | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
11:15-11:30 | 11:15-11:30 |
NOAC - A Monument Standing on the Shoulders of Giants |
Guosheng Fu | Sir Run Run Shaw Hospital |
11:30-11:45 | 11:30-11:45 |
Progress in Anticoagulant Management in 2020 ESC Guideline of Atrial Fibrillation |
Yihong Sun | China-Japan Friendship Hospital |
11:45-12:00 | 11:45-12:00 |
The Clinical Significance of ONTARGET Study and Its Subgroup Analysis of Chinese Population |
Yuqing Zhang | Beijing Fuwai Hospital |
12:00-12:30 | 12:00-12:30 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
14:00-14:15 | 14:00-14:15 |
Progress in Electrophysiological Mechanism of Atrial Fibrillation |
Yan Yao | |
14:15-14:22 | 14:15-14:22 |
Discussion |
||
14:22-14:37 | 14:22-14:37 |
Atrial Cardiomyopathy and Atrial Fibrillation |
Gang Yang | Jiangsu Province Hospital |
14:37-14:44 | 14:37-14:44 |
Discussion |
||
14:44-14:59 | 14:44-14:59 |
Rotor Theory and Atrial Fibrillation |
Xu Liu | |
14:59-15:06 | 14:59-15:06 |
Discussion |
||
15:06-15:21 | 15:06-15:21 |
The Activation Difference in Endocardial and Epicardial in Atrial Fibrillation |
Lu Yu | Sir Rung Rung Shaw Hospital, Zhejiang University School Of Medicine |
15:21-15:30 | 15:21-15:30 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
16:00-16:15 | 16:00-16:15 |
Interpretation of 2020 ESC/EACTS Guidelines for Atrial Fibrillation |
Shaowen Liu | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
16:15-16:18 | 16:15-16:18 |
Discussion |
||
16:18-16:33 | 16:18-16:33 |
Lifestyle and Risk Factors Intervention in Patients with Atrial Fibrillation |
Quan Fang | |
16:33-16:36 | 16:33-16:36 |
Discussion |
||
16:36-16:51 | 16:36-16:51 |
Management of Atrial Fibrillation Patients with Heart Failure |
Ruiqin Xie | |
16:51-16:54 | 16:51-16:54 |
Discussion |
||
16:54-17:09 | 16:54-17:09 |
Drug Therapy of Atrial Fibrillation: Future and Prospect |
Xinchun Yang | Beijing Chaoyang Hospital, Capital Medical University |
17:09-17:12 | 17:09-17:12 |
Discussion |
||
17:12-17:27 | 17:12-17:27 |
New Therapeutic Options for Atrial Fibrillation |
Yumei Xue | Guangdong Provincial People's Hospital |
17:27-17:30 | 17:27-17:30 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
19:00-19:20 | 19:00-19:20 |
Updated Key Points of 2020 ESC Guideline on Atrial Fibrillation |
Yihong Sun | China-Japan Friendship Hospital |
19:20-19:40 | 19:20-19:40 |
Anticoagulation Management after Radiofrequency Catheter Ablation of Atrial Fibrillation |
Hua Fu | West China Hospital,Sichuan University |
19:40-20:00 | 19:40-20:00 |
Integrated Management of Elderly Patients with Atrial Fibrillation |
Jian Cao | The Second Medical Center of Chinese PLA General Hospital |
20:00-20:20 | 20:00-20:20 |
Focus on bleeding risk management in patient’s characteristics |
Hailong Tao | The First Affiliated Hospital of Zhengzhou University |
20:20-21:00 | 20:20-21:00 |
Anticoagulation Management in Complex Atrial Fibrillation Patients |
Kun Fang | |
20:40-21:00 | 20:40-21:00 |
Discussion |